Business
Organigram Pulls Sanity Group Into a Single Global Structure
TORONTO – Organigram Global Inc. did not wait out the calendar. Roughly four months after the April 2026 closing of its acquisition of Sanity Group GmbH, the Canadian Cannabis producer announced an accelerated integration of its German subsidiary under a unified global operating structure, backed by senior leadership changes and a restructured earnout agreement. The ...
Aurora Takes Ownership of UK Patient Supply Chain with Birmingham Acquisitions
EDMONTON – Aurora Cannabis Inc. has acquired two licensed UK pharmaceutical entities, consolidating vertical control of its distribution network in one of Europe's most active medical Cannabis markets. Through a wholly owned subsidiary, Aurora announced that it indirectly purchased all of the shares of Internode Pharma Limited, a licensed Cannabis importer and wholesaler, and HAP ...
Dazed Inc Powers Ahead with Dallas Expansion, Strong Q2 Gains and Buyback Strategy
AUSTIN – Dazed Inc., formerly MedX Holdings, Inc., released a broad corporate update covering retail expansion, Q2 2026 financials, a planned stock buyback, and product distribution gains. The headline addition is a signed franchise agreement for a new Lazydaze Coffeeshop in Dallas, bringing the total brand footprint to 13 stores, comprising 7 currently operating locations, ...
Analysis: The DEA Is Now Fighting to Move Cannabis to Schedule III
WASHINGTON, D.C.,- For more than 50 years, the Drug Enforcement Administration has helped enforce federal Cannabis prohibition. This week, the DEA formally argued that Cannabis no longer belongs in Schedule I. In its final written argument following 11 days of hearings, the agency defended moving Cannabis from Schedule I to Schedule III and rejected the ...
Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split
TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company operating in Israel and Germany, announced that its board has approved a one-for-thirty share consolidation, effective August 27, with September 15 as the outside date. The consolidation will reduce roughly 18.1 million of its issued and outstanding common shares to approximately 603,900, subject to fractional ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is sized at $85 million at a pre-money valuation of $190 million. The financing has not yet closed. The structural terms ...
Analysis: Wall Street Quietly Tests the Water In Cannabis
NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on the sidelines. Howard Lutnick with President Trump The latest 13F filings suggest that could be starting to change. Every ...
Earnings Season: Cannabis Operators Deliver a Different Kind of Q2 2026
LOS ANGELES – The Cannabis industry wraps up its second-quarter earnings, and the aggregate picture carries a theme that would have been harder to locate a few years ago. Operators are making money. Profitability, not revenue scale, is the number that commands attention now. Cannamonitor Decide has compiled every result released through mid-August, spanning operators ...
Yale Budget Lab Outlines Multibillion Dollar Future for Federal Cannabis
NEW HAVEN – The fiscal argument for federal Cannabis legalization now has an academic backbone. Yale University's Budget Lab released a comprehensive revenue analysis mapping out what a federal excise tax on Cannabis could realistically generate, and the range of variables that could push that figure considerably higher. According to the report, federal legalization paired ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – A hostile takeover bid, a Senate hemp vote that reset the enforcement calendar without solving anything, a state tax repeal with constitutional teeth, a dense Q2 earnings wave, and two landmark banking deals – the fortnight gave the industry more to process than most quarters do. 1. Hostile M&A & Corporate Restructuring ...
Glass House Brands Reports Q2 2026 Financial Results
LONG BEACH – Glass House Brands Inc. released its Q2 2026 financial results, reporting revenue of $47 million, nearly flat year-over-year but a 64% sequential improvement from Q1 2026. Biomass production reached a company record of 245,746 equivalent dry pounds, surpassing management's guidance and the 230,748 pounds produced in the same quarter last year. Cost ...
Curaleaf Launches $272 Million Hostile Takeover Battle for Aurora Cannabis
NEW YORK - Curaleaf Holdings has launched a hostile takeover battle for Aurora Cannabis, publicly announcing plans to take a US$272 million offer directly to Aurora’s shareholders after failing to secure the support of Aurora’s board. If completed, the deal would bring together two of the most recognizable companies in Cannabis and create a global ...
Ohio Cannabis Health & Business Summit Announces 2026 Event in Columbus
The sixth annual OCHBS will take place September 23–24 at the Greater Columbus Convention Center, with expanded programming and expo booths, a medical patient access program, and signature networking events at Stories on High and COSI. COLUMBUS, Ohio — The Ohio Cannabis Health & Business Summit (OCHBS), Ohio’s largest cannabis conference & expo, will return ...
Vireo Growth Authorizes Share Buyback Program
MINNEAPOLIS – Vireo Growth Inc. has received board approval to begin a share repurchase plan under a normal course issuer bid. Following a series of strategic moves, including an expansion into Ohio and an earlier share consolidation, the company continues to build momentum as it integrates its recent acquisitions and broadens operational footprint. The multisite ...
Tyson 2.0 Teams Up with Reborn Roots for a Heavyweight Touchdown in Rhode Island
LOS ANGELES – Celebrity Cannabis brands have tested markets from the Pacific Northwest to the Caribbean and one of the sector's most recognized names is now pushing into New England. Tyson 2.0 Inc. announced an exclusive licensing agreement with Reborn Roots LLC, bringing the brand's full product lineup to Rhode Island dispensaries for both adult-use ...
Ascend Wellness Reports Q2 2026 Financial Results
NEW YORK – Ascend Wellness Holdings Inc. reported its Q2 2026 financial results posting net revenue of $126.1 million, a 7.9% sequential increase from $116.9 million in Q1 2026. Retail revenue climbed 11.5% quarter-over-quarter to $92.7 million, accounting for 73.5% of total net revenue, up from 71.1% in the prior period. Wholesale revenue held near ...
Organigram Reports Q3 Fiscal 2026 Financial Results
TORONTO – Organigram Global Inc. released its third-quarter fiscal 2026 results, showing the first full contribution from its recent European acquisition alongside continued strength in the Canadian market. The company reported higher sales and adjusted profitability for the period. Net revenue reached $105.8 million, up 49% from the same quarter a year earlier. Gross revenue ...
Curaleaf States Intention to Bid for Aurora Cannabis
STAMFORD – Curaleaf Holdings Inc. has publicly outlined plans to purchase all of the issued and outstanding common shares of Aurora Cannabis Inc., moving the proposal directly to shareholders after earlier private outreach. The announcement marks a notable step in cross-border consolidation within the Cannabis sector. In a statement, Curaleaf said it intends to offer ...
Vireo Growth Reports Q2 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. reported GAAP revenue of $209.3 million for the three months ended June 30, 2026, up 335% year-over-year from $48.1 million in Q2 2025, driven by the Eaze, Hawthorne Gardening Company, and Bridgewell Agribusiness transactions, all of which closed during the quarter. Total Cannabis revenue reached $175.8 million for the period, ...
Vireo Growth Closes Colorado Retail Deal, Secures Bank-Led Credit Line
MINNEAPOLIS – Vireo Growth Inc. announced it had received all required regulatory approvals and formally closed its acquisition of certain Colorado retail assets from PharmaCann Inc. Additionally, the company disclosed a senior secured asset-based revolving credit facility arranged through Bank of Montreal. The PharmaCann transaction, first announced in December 2025, transferred 17 operational dispensaries, along ...
Trulieve Reports Q2 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. released its second-quarter 2026 financial results, reflecting a period that included the deconsolidation of Harvest operations, recognition from TIME magazine, and the company's listing on the New York Stock Exchange. The medical Cannabis operator outlined revenue, margins and cash generation while noting several operational and strategic steps. Revenue for the ...
NY Cannabis Market Gains New Outdoor Sales Path
NEW YORK – New York Governor Kathy Hochul signed legislation that expands the ways licensed microbusinesses and dispensaries can sell Cannabis products at approved community events. The measure aims to give smaller operators more direct access to consumers while reinforcing the state’s regulated market. The Assembly Bill A11217 clarifies that vertically integrated microbusinesses can fully ...
High Tide Closes BMO Credit Facility, Issues Q3 Guidance
CALGARY – High Tide Inc. closed its C$40 million senior secured credit facilities with Bank of Montreal (BMO), replacing an existing arrangement with ConnectFirst Credit Union and substantially lowering the company's cost of capital. The transaction marks the first time the Cannabis operator has secured a senior lending relationship with a Big Five Canadian chartered ...
LEEF Brands Reports Q2 2026 Financial Results
VANCOUVER – LEEF Brands Inc. posted gross profit up 62% and gross margin that nearly doubled year-over-year, even as top-line revenue fell by 16%. Net revenue reached $7.3 million, down from $8.7 million in Q2 2025, primarily reflecting lower volumes while the company operated with a temporary biomass gap between 2025 and 2026 harvests from ...
ACT LAB Enters NJ Cannabis Market with Sriven Labs Acquisition
TRENTON – ACT LAB, a Cannabis and hemp testing and compliance laboratory network, announced its entry into New Jersey through the acquisition of Sriven Labs (SV Labs – NJ), a licensed and ISO-accredited testing laboratory that has served the state's regulated operators since its founding. The New Jersey Cannabis Regulatory Commission approved the deal. The ...
